Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

NCT01029886 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

912

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide once weekly
DRUG: liraglutide

Sponsor

AstraZeneca

Collaborators

[object Object]